Zhejiang NHU Company Ltd.

¥26.76As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002001Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 14.70%
Div yield 3.74%
ROE 21.26%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.26
PE TTM 11.24
TSR TTM 13.45%
Mkt cap ¥82.05B
ROIC 22.53%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥28
3.04%
(45.12%)
Hold 5|8|7|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.64
0.70
0.73
0.79
30.49%
35.20%
32.17%
29.66%
Revenue¥B
5.029
4.971
4.932
5.084
5.44%
7.42%
1.82%
1.17%
Peers (US$12.30B)
Cap (US$)
PE
16.31B
—
14.75B
18.94x
8.673B
17.73x
Capital
TTM
5Y
10Y
Leveragex
1.616
0.318
0.261
EBIT/Intx
1.933
0.140
0.157
Own earn%
10.38
98.64
63.89
Sh yield%
37.88
28.64
28.41
Owners
Insiders/Inst%
9.38
31.23
Short interest%
5.20
SBC / revenue%
4.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
4–15
$1 testx
—
Incr. ROIC%
1